BP
RGEN icon

Ballentine Partners’s Repligen RGEN Stock Holding History

Ballentine Partners’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,759
Closed -$224K – 1052
2025
Q1 		$224K Sell
1,759
-120
-6% -$18.5K ﹤0.01% 751
2024
Q4 		$270K Buy
1,879
+72
+4% +$10.3K ﹤0.01% 640
2024
Q3 		$269K Buy
1,807
+105
+6% +$15.1K ﹤0.01% 629
2024
Q2 		$215K Sell
1,702
-947
-36% -$148K ﹤0.01% 672
2024
Q1 		$487K Sell
2,649
-2
-0.1% -$381 0.01% 395
2023
Q4 		$477K Buy
2,651
+874
+49% +$136K 0.01% 377
2023
Q3 		$283K Sell
1,777
-429
-19% -$70.1K 0.01% 456
2023
Q2 		$312K Buy
2,206
+478
+28% +$76.6K 0.01% 440
2023
Q1 		$291K Sell
1,728
-22
-1% -$3.92K 0.01% 423
2022
Q4 		$296K Sell
1,750
-138
-7% -$25K 0.01% 385
2022
Q3 		$353K Sell
1,888
-19
-1% -$4.01K 0.01% 305
2022
Q2 		$310K Sell
1,907
-127
-6% -$20.1K 0.01% 321
2022
Q1 		$382K Sell
2,034
-2
-0.1% -$380 0.01% 303
2021
Q4 		$539K Buy
2,036
+2
+0.1% +$539 0.02% 251
2021
Q3 		$588K Buy
2,034
+3
+0.1% +$770 0.02% 215
2021
Q2 		$405K Buy
2,031
+7
+0.3% +$1.36K 0.01% 269
2021
Q1 		$393K Sell
2,024
-193
-9% -$39.6K 0.01% 258
2020
Q4 		$425K Buy
2,217
+7
+0.3% +$1.27K 0.02% 234
2020
Q3 		$326K Buy
2,210
+12
+0.5% +$1.72K 0.01% 281
2020
Q2 		$272K Sell
2,198
-14
-0.6% -$1.65K 0.01% 297
2020
Q1 		$213K Sell
2,212
-95
-4% -$9.17K 0.01% 304
2019
Q4 		$213K Buy
+2,307
New +$194K 0.01% 365

Other funds holding RGEN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Ballentine Partners's RGEN Position: Q2 2025 in Review

Ballentine Partners sold out of Repligen (RGEN) in Q2 2025, closing a stake of 1,759 shares — an estimated $224K sold.

Ballentine Partners first reported a position in RGEN in Q4 2019 and held it in 22 quarters. The position peaked at $588K in Q3 2021. 444 funds tracked by Wall St. Rank hold RGEN as of Q2 2025.

  • Ballentine Partners reported no remaining Repligen position as of Q2 2025 after selling out during the quarter.
  • Ballentine Partners sold 1,759 Repligen shares in Q2 2025, an estimated $224K.
  • Ballentine Partners first reported a position in Repligen in Q4 2019 and held it in 22 quarters.
  • Ballentine Partners's Repligen position peaked at $588K in Q3 2021.
  • 444 funds tracked by Wall St. Rank held Repligen as of Q2 2025.

Based on Ballentine Partners's 13F filing for Q2 2025, filed 15 Jul 2025.